Invokamet XR canagliflozin/metformin extended release regulatory update

FDA approved an NDA for Invokamet XR canagliflozin/metformin extended release from Johnson & Johnson’s Janssen Pharmaceuticals Inc. unit for first-line use as an adjunct to diet and exercise to improv...